UB Paderborn / Katalog / Suche / in CDI

Evaluation of Molecular Properties versus In Vivo Performance of Aflibercept, Brolucizumab, and Ranibizumab in a Retinal Vascular Hyperpermeability Model

Translational vision science & technology, 2022-10, Vol.11 (10), p.36-36

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunomodulatory Effect of the Topical Ophthalmic Janus Kinase Inhibitor Tofacitinib (CP-690,550) in Patients with Dry Eye Disease

Ophthalmology (Rochester, Minn.), 2012-07, Vol.119 (7), p.e43-e50

2012

Link zum Volltext

Verfügbarkeit prüfen

Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study

Ophthalmology and therapy, 2024-01, Vol.13 (1), p.179-203

2024

Link zum Volltext

Verfügbarkeit prüfen

VEGFR1 signaling in retinal angiogenesis and microinflammation

Progress in retinal and eye research, 2021-09, Vol.84, p.100954-100954, Article 100954

2021

Link zum Volltext

Verfügbarkeit prüfen

Retina expression and cross-species validation of gene silencing by PF-655, a small interfering RNA against RTP801 for the treatment of ocular disease

Journal of ocular pharmacology and therapeutics, 2012-06, Vol.28 (3), p.222

2012

Link zum Volltext

Verfügbarkeit prüfen

Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies

Ophthalmology retina, 2019-07, Vol.3 (7), p.553-560

2019

Link zum Volltext

Verfügbarkeit prüfen

Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model

Translational vision science & technology, 2023-05, Vol.12 (5), p.17-17

2023

Link zum Volltext

Verfügbarkeit prüfen

Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model

Translational vision science & technology, 2023-10, Vol.12 (10), p.5-5

2023

Link zum Volltext

Verfügbarkeit prüfen

Drug and gene delivery to the back of the eye: from bench to bedside

Investigative ophthalmology & visual science, 2014-04, Vol.55 (4), p.2714-2730

2014

Link zum Volltext

Verfügbarkeit prüfen

Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications

Investigative ophthalmology & visual science, 2010-11, Vol.51 (11), p.5403-5420

2010

Link zum Volltext

Verfügbarkeit prüfen

Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease

Investigative ophthalmology & visual science, 2012-07, Vol.53 (8), p.4556-4564

2012

Link zum Volltext

Verfügbarkeit prüfen

Durability of VEGF Suppression With Intravitreal Aflibercept and Brolucizumab: Using Pharmacokinetic Modeling to Understand Clinical Outcomes

Translational vision science & technology, 2021-04, Vol.10 (4), p.9-9

2021

Link zum Volltext

Verfügbarkeit prüfen

Plasma levels of amyloid beta and other proinflammatory mediators in patients with age-related macular degeneration

Graefe's archive for clinical and experimental ophthalmology, 2015-08, Vol.253 (8), p.1347-1354

2015

Link zum Volltext

Verfügbarkeit prüfen

RTP801 gene expression is differentially upregulated in retinopathy and is silenced by PF-04523655, a 19-Mer siRNA directed against RTP801

Investigative ophthalmology & visual science, 2014-03, Vol.55 (3), p.1232-1240

2014

Link zum Volltext

Verfügbarkeit prüfen

Measuring cone density in a Japanese macaque (Macaca fuscata) model of age-related macular degeneration with commercially available adaptive optics

Advances in experimental medicine and biology, 2014, Vol.801, p.309

2014

Link zum Volltext

Verfügbarkeit prüfen

The localization of PGE2 receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost

Neurochemistry international, 2009-09, Vol.55 (4), p.199-207

2009

Link zum Volltext

Verfügbarkeit prüfen

Expression of Prostaglandin PGE2 Receptors under Conditions of Aging and Stress and the Protective Effect of the EP2 Agonist Butaprost on Retinal Ischemia

Investigative ophthalmology & visual science, 2009-07, Vol.50 (7), p.3238-3248

2009

Link zum Volltext

Verfügbarkeit prüfen

Ocular pharmacokinetics of fluocinolone acetonide after retisert intravitreal implantation in rabbits over a 1-year period

Journal of ocular pharmacology and therapeutics, 2004-06, Vol.20 (3), p.269-275

2004

Link zum Volltext

Verfügbarkeit prüfen

Microdialysis assessment of drug delivery systems for vitreoretinal targets

Advanced drug delivery reviews, 2005-12, Vol.57 (14), p.2080-2091

2005

Link zum Volltext

Verfügbarkeit prüfen

Microdialysis and drug delivery to the eye

Advanced drug delivery reviews, 2000-12, Vol.45 (2), p.229-241

2000

Link zum Volltext

Verfügbarkeit prüfen

Microdialysis evaluation of the ocular pharmacokinetics of propranolol in the conscious rabbit

Pharmaceutical research, 1999-05, Vol.16 (5), p.736-742

1999

Link zum Volltext

Verfügbarkeit prüfen

The localization of PGE sub(2) receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost

Neurochemistry international, 2009-09, Vol.55 (4), p.199-207

2009

Link zum Volltext

Verfügbarkeit prüfen

The localization of PGE 2 receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost

Neurochemistry international, 2009, Vol.55 (4), p.199-207

2009

Link zum Volltext

Verfügbarkeit prüfen

Microdialysis assessment of drug delivery systems for vitreoretinal targets: Drug delivery strategies to treat age-related macular degeneration

Advanced drug delivery reviews, 2005, Vol.57 (14), p.2080-2091

2005

Link zum Volltext

Verfügbarkeit prüfen

Microdialysis and drug delivery to the eye: Use of Microdialysis in Drug Delivery Studies

Advanced drug delivery reviews, 2000, Vol.45 (2-3), p.229-241

2000

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Evaluation of Molecular Properties versus In Vivo Performance of Aflibercept, Brolucizumab, and Ranibizumab in a Retinal Vascular Hyperpermeability Model

Immunomodulatory Effect of the Topical Ophthalmic Janus Kinase Inhibitor Tofacitinib (CP-690,550) in Patients with Dry Eye Disease

Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study

VEGFR1 signaling in retinal angiogenesis and microinflammation

Retina expression and cross-species validation of gene silencing by PF-655, a small interfering RNA against RTP801 for the treatment of ocular disease

Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies

Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model

Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model

Drug and gene delivery to the back of the eye: from bench to bedside

Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications

Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease

Durability of VEGF Suppression With Intravitreal Aflibercept and Brolucizumab: Using Pharmacokinetic Modeling to Understand Clinical Outcomes

Plasma levels of amyloid beta and other proinflammatory mediators in patients with age-related macular degeneration

RTP801 gene expression is differentially upregulated in retinopathy and is silenced by PF-04523655, a 19-Mer siRNA directed against RTP801

Measuring cone density in a Japanese macaque (Macaca fuscata) model of age-related macular degeneration with commercially available adaptive optics

The localization of PGE2 receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost

Expression of Prostaglandin PGE2 Receptors under Conditions of Aging and Stress and the Protective Effect of the EP2 Agonist Butaprost on Retinal Ischemia

Ocular pharmacokinetics of fluocinolone acetonide after retisert intravitreal implantation in rabbits over a 1-year period

Microdialysis assessment of drug delivery systems for vitreoretinal targets

Microdialysis and drug delivery to the eye

Microdialysis evaluation of the ocular pharmacokinetics of propranolol in the conscious rabbit

The localization of PGE sub(2) receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost

The localization of PGE 2 receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost

Microdialysis assessment of drug delivery systems for vitreoretinal targets: Drug delivery strategies to treat age-related macular degeneration

Microdialysis and drug delivery to the eye: Use of Microdialysis in Drug Delivery Studies

Suchergebnisse filtern